Emergent BioSolutions Files 8-K on Financials
Ticker: EBS · Form: 8-K · Filed: May 7, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Emergent BioSolutions dropped an 8-K on May 7th detailing financial results and exhibits.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on May 7, 2025, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Gaithersburg, Maryland.
Why It Matters
This 8-K filing provides crucial updates on Emergent BioSolutions' financial performance and operational status, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This filing is a standard 8-K reporting financial information and does not indicate any immediate or unusual risks.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- May 7, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, Maryland (location) — Principal executive offices
- 240-631-3200 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Emergent BioSolutions Inc.'s results of operations and financial condition, as well as to include Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 7, 2025.
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc.'s principal executive offices are located at 300 Professional Drive, Gaithersburg, Maryland 20879.
What is the SEC file number for Emergent BioSolutions Inc.?
The SEC file number for Emergent BioSolutions Inc. is 001-33137.
What is the standard industrial classification for Emergent BioSolutions Inc.?
The standard industrial classification for Emergent BioSolutions Inc. is Pharmaceutical Preparations [2834].
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding Emergent BioSolutions Inc. (EBS).